HK Stock MarketDetailed Quotes

02269 WUXI BIO

Watchlist
  • 16.320
  • -0.020-0.12%
Market Closed Nov 1 16:08 CST
67.80BMarket Cap23.52P/E (TTM)

WUXI BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
0.97%8.57B
11.56%17.03B
17.84%8.49B
48.38%15.27B
63.53%7.21B
83.35%10.29B
126.67%4.41B
40.88%5.61B
20.97%1.94B
57.18%3.98B
Operating income
0.97%8.57B
11.56%17.03B
17.84%8.49B
48.38%15.27B
63.53%7.21B
83.35%10.29B
126.67%4.41B
40.88%5.61B
20.97%1.94B
57.18%3.98B
Cost of sales
-5.94%-5.22B
-19.45%-10.21B
-30.01%-4.93B
-56.46%-8.54B
-79.78%-3.79B
-77.34%-5.46B
-82.39%-2.11B
-32.46%-3.08B
-23.58%-1.16B
-53.28%-2.32B
Operating expenses
-5.94%-5.22B
-19.45%-10.21B
-30.01%-4.93B
-56.46%-8.54B
-79.78%-3.79B
-77.34%-5.46B
-82.39%-2.11B
-32.46%-3.08B
-23.58%-1.16B
-53.28%-2.32B
Gross profit
-5.92%3.35B
1.55%6.83B
4.32%3.56B
39.25%6.72B
48.60%3.41B
90.64%4.83B
191.73%2.3B
52.70%2.53B
17.33%787.31M
62.99%1.66B
Selling expenses
-111.65%-223.06M
-80.47%-294.01M
-57.06%-105.39M
-30.70%-162.91M
-11.18%-67.1M
-32.02%-124.65M
-24.55%-60.36M
-22.49%-94.42M
-83.94%-48.46M
-81.66%-77.08M
Administrative expenses
-13.73%-772.99M
-17.78%-1.5B
-30.67%-679.64M
-44.94%-1.27B
-49.61%-520.11M
-71.27%-875.93M
-70.93%-347.64M
-39.25%-511.44M
-35.85%-203.38M
-61.29%-367.29M
Research and development expenses
-0.77%-344.06M
-15.09%-785.82M
-25.93%-341.44M
-36.13%-682.82M
-135.00%-271.13M
-65.14%-501.58M
7.27%-115.38M
-16.98%-303.73M
-14.02%-124.41M
-53.38%-259.65M
Impairment and provision
-44.29%-190.17M
-23.77%-319.97M
-86.05%-131.8M
-65.02%-258.53M
46.80%-70.84M
-29.41%-156.67M
-135.33%-133.17M
-1,669.39%-121.06M
-492.22%-56.59M
87.77%-6.84M
-Other impairment is provision
-44.29%-190.17M
-23.77%-319.97M
-86.05%-131.8M
-65.02%-258.53M
46.80%-70.84M
-29.41%-156.67M
-135.33%-133.17M
-1,669.39%-121.06M
-492.22%-56.59M
87.77%-6.84M
Special items of operating profit
-15.93%256.78M
-62.73%399.54M
-34.84%305.43M
24.33%1.07B
6.83%468.77M
71.24%862.24M
17.28%438.81M
150.03%503.54M
167.12%374.15M
-6.48%201.39M
Operating profit
-20.38%2.08B
-20.10%4.33B
-11.68%2.61B
34.47%5.42B
42.02%2.95B
101.03%4.03B
185.35%2.08B
74.52%2.01B
41.11%728.61M
55.80%1.15B
Financing cost
13.63%-68.07M
-146.17%-158.49M
-247.82%-78.82M
-64.28%-64.38M
-8.56%-22.66M
8.29%-39.19M
6.83%-20.87M
-117.96%-42.73M
-385.90%-22.41M
---19.61M
Share of profits of associates
----
----
----
----
----
----
----
184.39%2.63M
-456.31%-1.1M
---3.12M
Earning before tax
-20.59%2.01B
-22.10%4.17B
-13.69%2.53B
34.18%5.36B
42.36%2.93B
103.13%3.99B
191.90%2.06B
74.48%1.97B
37.70%705.11M
52.72%1.13B
Tax
-19.33%-228.07M
25.34%-603.18M
38.13%-191.12M
-66.73%-807.87M
-76.07%-308.91M
-77.44%-484.54M
-785.41%-175.45M
-134.80%-273.07M
140.92%25.6M
-8.43%-116.3M
After-tax profit from continuing operations
-23.85%1.78B
-21.52%3.57B
-10.81%2.34B
29.68%4.55B
39.22%2.62B
107.28%3.51B
157.67%1.88B
67.54%1.69B
62.57%730.7M
60.25%1.01B
Earning after tax
-23.85%1.78B
-21.52%3.57B
-10.81%2.34B
29.68%4.55B
39.22%2.62B
107.28%3.51B
157.67%1.88B
67.54%1.69B
62.57%730.7M
60.25%1.01B
Minority profit
295.07%281.23M
31.84%170.9M
-17.38%71.19M
7.92%129.62M
112.02%86.16M
3,053.97%120.1M
851.30%40.64M
209.80%3.81M
-869.35%-5.41M
-2,630.71%-3.47M
Profit attributable to shareholders
-33.86%1.5B
-23.09%3.4B
-10.59%2.27B
30.45%4.42B
37.62%2.54B
100.63%3.39B
150.25%1.84B
66.59%1.69B
63.57%736.11M
60.77%1.01B
Basic earnings per share
-32.73%0.37
-22.64%0.82
-9.84%0.55
30.86%1.06
38.64%0.61
88.37%0.81
131.58%0.44
59.26%0.43
-48.65%0.19
-48.08%0.27
Diluted earnings per share
-32.69%0.35
-23.76%0.77
-10.34%0.52
31.17%1.01
38.10%0.58
92.50%0.77
133.33%0.42
60.00%0.4
-47.06%0.18
-47.92%0.25
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 0.97%8.57B11.56%17.03B17.84%8.49B48.38%15.27B63.53%7.21B83.35%10.29B126.67%4.41B40.88%5.61B20.97%1.94B57.18%3.98B
Operating income 0.97%8.57B11.56%17.03B17.84%8.49B48.38%15.27B63.53%7.21B83.35%10.29B126.67%4.41B40.88%5.61B20.97%1.94B57.18%3.98B
Cost of sales -5.94%-5.22B-19.45%-10.21B-30.01%-4.93B-56.46%-8.54B-79.78%-3.79B-77.34%-5.46B-82.39%-2.11B-32.46%-3.08B-23.58%-1.16B-53.28%-2.32B
Operating expenses -5.94%-5.22B-19.45%-10.21B-30.01%-4.93B-56.46%-8.54B-79.78%-3.79B-77.34%-5.46B-82.39%-2.11B-32.46%-3.08B-23.58%-1.16B-53.28%-2.32B
Gross profit -5.92%3.35B1.55%6.83B4.32%3.56B39.25%6.72B48.60%3.41B90.64%4.83B191.73%2.3B52.70%2.53B17.33%787.31M62.99%1.66B
Selling expenses -111.65%-223.06M-80.47%-294.01M-57.06%-105.39M-30.70%-162.91M-11.18%-67.1M-32.02%-124.65M-24.55%-60.36M-22.49%-94.42M-83.94%-48.46M-81.66%-77.08M
Administrative expenses -13.73%-772.99M-17.78%-1.5B-30.67%-679.64M-44.94%-1.27B-49.61%-520.11M-71.27%-875.93M-70.93%-347.64M-39.25%-511.44M-35.85%-203.38M-61.29%-367.29M
Research and development expenses -0.77%-344.06M-15.09%-785.82M-25.93%-341.44M-36.13%-682.82M-135.00%-271.13M-65.14%-501.58M7.27%-115.38M-16.98%-303.73M-14.02%-124.41M-53.38%-259.65M
Impairment and provision -44.29%-190.17M-23.77%-319.97M-86.05%-131.8M-65.02%-258.53M46.80%-70.84M-29.41%-156.67M-135.33%-133.17M-1,669.39%-121.06M-492.22%-56.59M87.77%-6.84M
-Other impairment is provision -44.29%-190.17M-23.77%-319.97M-86.05%-131.8M-65.02%-258.53M46.80%-70.84M-29.41%-156.67M-135.33%-133.17M-1,669.39%-121.06M-492.22%-56.59M87.77%-6.84M
Special items of operating profit -15.93%256.78M-62.73%399.54M-34.84%305.43M24.33%1.07B6.83%468.77M71.24%862.24M17.28%438.81M150.03%503.54M167.12%374.15M-6.48%201.39M
Operating profit -20.38%2.08B-20.10%4.33B-11.68%2.61B34.47%5.42B42.02%2.95B101.03%4.03B185.35%2.08B74.52%2.01B41.11%728.61M55.80%1.15B
Financing cost 13.63%-68.07M-146.17%-158.49M-247.82%-78.82M-64.28%-64.38M-8.56%-22.66M8.29%-39.19M6.83%-20.87M-117.96%-42.73M-385.90%-22.41M---19.61M
Share of profits of associates ----------------------------184.39%2.63M-456.31%-1.1M---3.12M
Earning before tax -20.59%2.01B-22.10%4.17B-13.69%2.53B34.18%5.36B42.36%2.93B103.13%3.99B191.90%2.06B74.48%1.97B37.70%705.11M52.72%1.13B
Tax -19.33%-228.07M25.34%-603.18M38.13%-191.12M-66.73%-807.87M-76.07%-308.91M-77.44%-484.54M-785.41%-175.45M-134.80%-273.07M140.92%25.6M-8.43%-116.3M
After-tax profit from continuing operations -23.85%1.78B-21.52%3.57B-10.81%2.34B29.68%4.55B39.22%2.62B107.28%3.51B157.67%1.88B67.54%1.69B62.57%730.7M60.25%1.01B
Earning after tax -23.85%1.78B-21.52%3.57B-10.81%2.34B29.68%4.55B39.22%2.62B107.28%3.51B157.67%1.88B67.54%1.69B62.57%730.7M60.25%1.01B
Minority profit 295.07%281.23M31.84%170.9M-17.38%71.19M7.92%129.62M112.02%86.16M3,053.97%120.1M851.30%40.64M209.80%3.81M-869.35%-5.41M-2,630.71%-3.47M
Profit attributable to shareholders -33.86%1.5B-23.09%3.4B-10.59%2.27B30.45%4.42B37.62%2.54B100.63%3.39B150.25%1.84B66.59%1.69B63.57%736.11M60.77%1.01B
Basic earnings per share -32.73%0.37-22.64%0.82-9.84%0.5530.86%1.0638.64%0.6188.37%0.81131.58%0.4459.26%0.43-48.65%0.19-48.08%0.27
Diluted earnings per share -32.69%0.35-23.76%0.77-10.34%0.5231.17%1.0138.10%0.5892.50%0.77133.33%0.4260.00%0.4-47.06%0.18-47.92%0.25
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data